Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Thorben, Mährle"'
Autor:
Anne-Marie Asemissen, Feline von Feldmann, Roswitha Dickerhoff, Corinna Güsmer, Carsten Bokemeyer, Thorben Mährle
Publikováno v:
HemaSphere, Vol 7, p e8092624 (2023)
Externí odkaz:
https://doaj.org/article/86a05025157b4e0484ccac2073e9b8ac
Autor:
Donjete Simnica, Nuray Akyüz, Simon Schliffke, Malte Mohme, Lisa v.Wenserski, Thorben Mährle, Lorenzo F. Fanchi, Katrin Lamszus, Mascha Binder
Publikováno v:
OncoImmunology, Vol 8, Iss 11 (2019)
The dynamics of immunoaging and the onset of immunoparesis in healthy individuals and cancer patients has been controversially discussed. Moreover, the role of chemotherapy on T cell regeneration needs further elucidation in light of novel immunother
Externí odkaz:
https://doaj.org/article/4a179c990bdc4425aaa7935ba3ca0ff6
Autor:
Thorben Mährle, Nuray Akyüz, Pim Fuchs, Nicola Bonzanni, Donjete Simnica, Ulrich Germing, Anne Marie Asemissen, Johann Christoph Jann, Florian Nolte, Wolf-Karsten Hofmann, Daniel Nowak, Mascha Binder
Publikováno v:
Haematologica, Vol 104, Iss 7 (2019)
In myelodysplastic syndromes with a partial deletion of the long arm of chromosome 5, del(5q), lenalidomide is believed to reverse anergic T-cell immunity in the bone marrow resulting in suppression of the del(5q) clone. In this study we used next-ge
Externí odkaz:
https://doaj.org/article/117f91af580a484d85d483e48d847621
Autor:
Toni Thenhausen, Nuray Akyüz, Thorben Mährle, Sonja Loges, Eray Goekkurt, Julia Quidde, Alexander Stein, Carsten Bokemeyer, Benjamin Thiele, Anna Brandt, Simon Schliffke, Janina Radloff, Thomas Haalck, Mascha Binder, Anne Marie Asemissen, Christopher Thomas Ford, Artus Krohn-Grimberghe
Publikováno v:
International Journal of Cancer. 140:2535-2544
Cancer immunotherapy with antibodies targeting immune checkpoints, such as programmed cell death protein 1 (PD-1), shows encouraging results, but reliable biomarkers predicting response to this costly and potentially toxic treatment approach are stil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a2e5c9b06dcbec51c32fea54d0d0addc
https://doi.org/10.1002/ijc.30549
https://doi.org/10.1002/ijc.30549
Autor:
Ulrich Germing, Daniel Nowak, Mascha Binder, Donjete Simnica, Wolf-Karsten Hofmann, Anne Marie Asemissen, Nuray Akyüz, Nicola Bonzanni, Thorben Mährle, Johann Christoph Jann, Pim Fuchs, Florian Nolte
Publikováno v:
Haematologica
In myelodysplastic syndromes with a partial deletion of the long arm of chromosome 5, del(5q), lenalidomide is believed to reverse anergic T-cell immunity in the bone marrow resulting in suppression of the del(5q) clone. In this study we used next-ge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71569bd7e50c9cae4c6127433ef1726d
https://pubmed.ncbi.nlm.nih.gov/30655375
https://pubmed.ncbi.nlm.nih.gov/30655375
Autor:
Simon Schliffke, Nuray Akyüz, S Knop, Christopher Thomas Ford, Manfred Binder, Artus Krohn-Grimberghe, Toni Thenhausen, Carsten Bokemeyer, Thorben Mährle
Publikováno v:
Leukemia. 30:2232-2234
Clinical response to ibrutinib is accompanied by normalization of the T-cell environment in CLL-related autoimmune cytopenia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::20079857300d12e2ff834f0f2efb11a4
https://doi.org/10.1038/leu.2016.157
https://doi.org/10.1038/leu.2016.157
Autor:
Nuray, Akyüz, Anna, Brandt, Alexander, Stein, Simon, Schliffke, Thorben, Mährle, Julia, Quidde, Eray, Goekkurt, Sonja, Loges, Thomas, Haalck, Christopher Thomas, Ford, Anne Marie, Asemissen, Benjamin, Thiele, Janina, Radloff, Toni, Thenhausen, Artus, Krohn-Grimberghe, Carsten, Bokemeyer, Mascha, Binder
Publikováno v:
International journal of cancer. 140(11)
Cancer immunotherapy with antibodies targeting immune checkpoints, such as programmed cell death protein 1 (PD-1), shows encouraging results, but reliable biomarkers predicting response to this costly and potentially toxic treatment approach are stil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::903b9b32d3ac99e9e153d3ee870a2954
https://pubmed.ncbi.nlm.nih.gov/27925177
https://pubmed.ncbi.nlm.nih.gov/27925177